Skip to content

Clinical trials

Phase 2 Stomach Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stomach Neoplasms Phase: Phase 2 Country / region: United States Clear all

215 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200010
20019
20029
20038
200412
20057
20068
20075
20087
20097
20104
20118
20128
20136
20141
20155
20162
201711
201812
20198
202010
20217
20224
20237
20248
20257
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed130
Terminated30
Recruiting21
Active, not recruiting15
Unknown status9
Withdrawn5
Not yet recruiting3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)21
Memorial Sloan Kettering Cancer Center18
Dana-Farber Cancer Institute9
Alliance for Clinical Trials in Oncology8
NYU Langone Health6
AstraZeneca5
SWOG Cancer Research Network5
University of California, Irvine5
Eli Lilly and Company4
Bristol-Myers Squibb3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stomach Neoplasms215
Esophageal Neoplasms94
Colorectal Neoplasms23
Pancreatic Neoplasms23
Ovarian Neoplasms18
Carcinoma, Hepatocellular17
Adenocarcinoma14
Breast Neoplasms13
Carcinoma, Non-Small-Cell Lung13
Neoplasm Metastasis13

Trials

Showing 1 to 25 of 215. Each trial links to its page on Pharma Observatory.

115 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.